The GABA a receptor subunits heterologously expressed in Xenopus oocytes

Mini-Reviews in Medicinal Chemistry

Volumn 13, Issue 5, 2013, Pages 744-748

  Abdullah, Jafri Malin ^a   Zhang, Jingli ^a  

^a SCHOOL OF MEDICAL SCIENCES   (Malaysia)

Author keywords

CDNA; cRNA; GABA a receptor; Subunits; Two electrode voltage clamp; Xenopus laevis oocytes

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA1; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA2; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA3; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA4; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA5; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA6; 4 AMINOBUTYRIC ACID A RECEPTOR BETA1; 4 AMINOBUTYRIC ACID A RECEPTOR BETA2; 4 AMINOBUTYRIC ACID A RECEPTOR BETA3; 4 AMINOBUTYRIC ACID A RECEPTOR GAMMA1; 4 AMINOBUTYRIC ACID A RECEPTOR GAMMA2; 4 AMINOBUTYRIC ACID A RECEPTOR GAMMA3; APIGENIN; BORNEOL; CYCLIC AMP DEPENDENT PROTEIN KINASE; NEUROSTEROID; TOPIRAMATE;

ARTICLE; EPILEPSY; HETEROLOGOUS EXPRESSION; HUMAN; NONHUMAN; OOCYTE; PROTEIN STRUCTURE; XENOPUS LAEVIS;

ANIMALS; BENZODIAZEPINES; OOCYTES; PROTEIN BINDING; PROTEIN SUBUNITS; RECEPTORS, GABA-A; XENOPUS LAEVIS;

EID: 84877823879     PISSN: 13895575     EISSN: 18755607     Source Type: Journal    
DOI: 10.2174/1389557511313050011     Document Type: Article

References (45)

1. Hall, A.C.; Griffith, T.N.; Tsikolia, M.; Kotey, F.O.; Gill, N.; Humbert, D.J.; Watt, E.E.; Yermolina, Y.A.; Goel, S.; El-Ghendy, B.; Hall, C.D. Cyclohexanol analogues are positive modulators of GABA(A) receptor currents and act as general anaesthetics in vivo. Eur. J. Pharmacol., 2011, 667, 175-181.
2. Berezhnoy, D.; Gravielle, M.C.; Downing, S.; Kostakis, E.; Basile, A.S.; Skolnick, P.; Gibbs, T.T.; Farb, D.H. Pharmacological Properties of DOV 315,090, an ocinaplon metabolite. BMC Pharmacol., 2008, 8, 11.
3. Rahman, M.; Zhu, D.; Lindblad C.; Johansson, I.M.; Holmberg, E.; Isaksson, M.; Taube, M.; Bäckström, T.; Wang, M.D. GABA-site antagonism and pentobarbital actions do not depend on the alpha-subunit type in the recombinant rat GABA receptor. Acta. Physiol. (Oxf), 2006, 187, 479-488.
4. Singhuber, J.; Baburin, I.; Ecker, G.F.; Kopp, B.; Hering, S. Insights into structure-activity relationship of GABA(A) receptor modulating coumarins and furanocoumarins. Eur. J. Pharmacol., 2011, 668, 57-64.
5. Chebib, M.; Hinton, T.; Schmid, K.L.; Brinkworth, D.; Qian, H.; Matos, S.; Kim, H.L.; Abdel-Halim, H.; Kumar, R.J.; Johnston, G.A.; Hanrahan, J.R. Novel, potent, and selective GABAC antagonists inhibit myopia development and facilitate learning and memory. J. Pharmacol. Exp. Ther., 2009, 328, 448-457.
6. You, H. and Dunn, S.M. Identification of a domain in the delta subunit (S238-V264) of the alpha4beta3delta GABAA receptor that confers high agonist sensitivity. J. Neurochem., 2007, 103, 1092-1101.
7. Kloda, J.H. and Czajkowski, C. Agonist-, antagonist-, and benzodiazepine-induced structural changes in the alpha1 Met113-Leu132 region of the GABAA receptor. Mol. Pharmacol., 2007, 71, 483-493.
8. Hall, B.J.; Chebib, M.; Hanrahan, J.R.; Johnston, G.A. Flumazenil-independent positive modulation of gamma-aminobutyric acid action by 6-methylflavone at human recombinant alpha1beta2gamma2L and alpha1beta2 GABAA receptors. Eur. J. Pharmacol., 2004, 491, 1-8.
9. Savić, M.M.; Clayton, T.; Furtmüller, R.; Gavrilović, I.; Samardzić, J.; Savić, S.; Huck, S.; Sieghart, W.; Cook, J.M. PWZ-029, a compound with moderate inverse agonist functional selectivity at GABA(A) receptors containing alpha5 subunits, improves passive, but not active, avoidance learning in rats. Brain Res., 2008, 1208, 150-159.
10. Savić, M.M.; Huang, S.; Furtmüller, R.; Clayton, T.; Huck, S.; Obradović, D.I.; Ugresić, N.D.; Sieghart, W.; Bokonjić, D.R.; Cook, J.M. Are GABAA receptors containing alpha5 subunits contributing to the sedative properties of benzodiazepine site agonists? Neuropsychopharmacology, 2008, 33, 332-339.
11. Atack, J.R.; Bayley, P.J.; Fletcher, S.R.; McKernan, R.M.; Wafford, K.A.; Dawson, G.R. The proconvulsant effects of the GABAA alpha5 subtype-selective compound RY-080 may not be alpha5-mediated. Eur. J. Pharmacol., 2006, 548, 77-82.
12. Gee, K.W.; Tran, M.B.; Hogenkamp, D.J.; Johnstone, T.B.; Bagnera, R.E.; Yoshimura, R.F.; Huang, J.C.; Belluzzi, J.D.; Whittemore, E.R. Limiting activity at beta1-subunit-containingGABAA receptor subtypes reduces ataxia. J. Pharmacol. Exp. Ther., 2010, 332, 1040-1053.
13. Fernandez, S.P.; Mewett, K.N.; Hanrahan, J.R.; Chebib, M.; Johnston, G.A. Flavan-3-ol derivatives are positive modulators of GABA(A) receptors with higher efficacy for the alpha(2) subtype and anxiolytic action in mice. Neuropharmacology, 2008, 55, 900-907.
14. Liu, X.F.; Chang, H.F.; Schmiesing, R.J.; Wesolowski, S.S.; Knappenberger, K.S.; Arriza, J.L.; Chapdelaine, M.J. Developing dual functional allosteric modulators of GABA(A) receptors. Bioorg. Med. Chem., 2010, 18, 8374-8382.
15. Rudolph, U.; Crestani, F.; Benke, D.; Brünig, I.; Benson, J.A.; Fritschy, J.M.; Martin, J.R.; Bluethmann, H.; Möhler, H. Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes. Nature, 1999, 401, 796-800.
16. Löw, K.; Crestani, F.; Keist, R.; Benke, D.; Brünig, I.; Benson, J.A.; Fritschy, J.M.; Rülicke, T.; Bluethmann, H.; Möhler, H.; Rudolph, U. Molecular and neuronal substrate for the selective attenuation of anxiety. Science, 2000, 290, 131-134.
17. Baur, R. and Kaur, K.H. Structure of alpha6 beta3 delta GABA(A) receptors and their lack of ethanol sensitivity. J. Neurochem., 2009, 111, 1172-1181.
18. Stórustovu, S.I. and Ebert, B. Pharmacological characterization of agonists at delta-containing GABAA receptors: Functional selectivity for extrasynaptic receptors is dependent on the absence of gamma2. J. Pharmacol. Exp. Ther., 2006, 316, 1351-1359.
19. Hoestgaard-Jensen, K.; Dalby, N.O.; Wolinsky, T.D.; Murphey, C.; Jones, K.A.; Rottländer, M.; Frederiksen, K.; Watson, W.P.; Jensen, K.; Ebert, B. Pharmacological characterization of a novel positive modulator at alpha 4 beta 3 delta-containing extrasynaptic GABA(A) receptors. Neuropharmacology, 2010, 58, 702-711.
20. Lovick, T.A.; Griffiths, J.L.; Dunn, S.M.; Martin, I.L. Changes in GABA(A) receptor subunit expression in the midbrain during the oestrous cycle in Wistar rats. Neuroscience, 2005, 131, 397-405.
21. Hadley, S.H. and Amin, J. Rat alpha6beta2delta GABAA receptors exhibit two distinct and separable agonist affinities. J. Physiol., 2007, 581, 1001-1018.
22. Santhakumar, V.; Hanchar, H.J.; Wallner, M.; Olsen, R.W.; Otis, T.S. Contributions of the GABAA receptor alpha6 subunit to phasic and tonic inhibition revealed by a naturally occurring polymorphism in the alpha6 gene. J. Neurosci., 2006, 26, 3357-3364.
23. Ranna, M.; Sinkkonen, S.T.; Möykkynen, T.; Uusi-Oukari, M.; Korpi, E.R. Impact of epsilon and theta subunits on pharmacological properties of alpha3beta1 GABAA receptors expressed in Xenopus oocytes. BMC Pharmacol., 2006, 6, 1.
24. Watt, E.E.; Betts, B.A.; Kotey, F.O.; Humbert, D.J.; Griffith, T.N.; Kelly, E.W.; Veneskey, K.C.; Gill, N.; Rowan, K.C.; Jenkins, A.; Hall, A.C. Menthol shares general anesthetic activity and sites of action on the GABA(A) receptor with the intravenous agent, propofol. Eur. J. Pharmacol., 2008, 590, 120-126.
25. Williams, D.B. A novel, rapid, inhibitory effect of insulin on alpha1beta2gamma2s gamma-aminobutyric acid type A receptors. Neurosci. Lett., 2008, 443, 27-31.
26. Krüger, K.; Diepgrond, V.; Ahnefeld, M.; Wackerbeck, C.; Madeja, M.; Binding, N.; Musshoff, U. Blockade of glutamatergic and GABAergic receptor channels by trimethyltin chloride. Br. J. Pharmacol., 2005, 144, 283-292.
27. Conti, L.; Palma, E.; Roseti, C.; Lauro, C.; Cipriani, R.; de Groot, M.; Aronica, E.; Limatola, C. Anomalous levels of Cl(-) transporters cause a decrease of GABAergic inhibition in human peritumoral epileptic cortex. Epilepsia, 2011, 52, 1635-1644.
28. Li, G.; Yang, K.; Zheng, C.; Liu, Q.; Chang, Y.; Kerrigan, J.F.; Wu, J. Functional rundown of gamma-aminobutyric acid(A) receptors in human hypothalamic hamartomas. Ann. Neurol., 2011, 69, 664-672.
29. Chambers, M.S.; Atack, J.R.; Broughton, H.B.; Collinson, N.; Cook, S.; Dawson, G.R.; Hobbs, S.C.; Marshall, G.; Maubach, K.A.; Pillai, G.V.; Reeve, A.J.; MacLeod, A.M. Identification of a novel, selective GABA(A) alpha5 receptor inverse agonist which enhances cognition. J. Med. Chem., 2003, 46, 2227-2240.
30. Campo-Soria, C.; Chang, Y.; Weiss, D.S. Mechanism of action of benzodiazepines on GABAA receptors. Br. J. Pharmacol., 2006, 148, 984-990.
31. Rüsch, D.; Zhong, H.; Forman, S.A. Gating allosterism at a single class of etomidate sites on alpha1beta2gamma2L GABA A receptors accounts for both direct activation and agonist modulation. J. Biol. Chem., 2004, 279, 20982-92092.
32. Yamashita, M.; Marszalec, W.; Yeh, J.Z.; Narahashi, T. Effects of ethanol on tonic GABA currents in cerebellar granule cells and mammalian cells recombinantly expressing GABA(A) receptors. J. Pharmacol. Exp. Ther., 2006, 319, 431-438.
33. Sancar, F. and Czajkowski, C. Allosteric modulators induce distinct movements at the GABA-binding site interface of the GABA-A receptor. Neuropharmacology, 2011, 60, 520-528.
34. Sharkey, L.M. and Czajkowski, C. Individually monitoring ligand-induced changes in the structure of the GABAA receptor at benzodiazepine binding site and non-binding-site interfaces. Mol. Pharmacol., 2008, 74, 203-212.
35. Simeone, T.A.; Wilcox, K.S.; White, H.S. cAMP-Dependent protein kinase A activity modulates topiramate potentiation of GABA(A) receptors. Epilepsy Res., 2011, 96, 176-179.
36. Palma, E.; Amici, M.; Sobrero, F.; Spinelli, G.; Di Angelantonio, S.; Ragozzino, D.; Mascia, A.; Scoppetta, C.; Esposito, V.; Miledi, R.; Eusebi, F. Anomalous levels of Cl-transporters in the hippocampal subiculum from temporal lobe epilepsy patients make GABA excitatory. Proc. Natl. Acad. Sci. U.S.A, 2006, 103, 8465-8468.
37. Boué-Grabot, E.; Toulmé, E.; Emerit, M.B.; Garret, M. Subunit-specific coupling between gamma-aminobutyric acid type A and P2X2 receptor channels. J. Biol. Chem., 2004, 279, 52517-52525.
38. Toulmé, E.; Blais, D.; Léger, C.; Landry, M.; Garret, M.; Séguéla, P.; Boué-Grabot, E. An intracellular motif of P2X(3) receptors is required for functional cross-talk with GABA(A) receptors in nociceptive DRG neurons. J. Neurochem., 2007, 102, 1357-1368.
39. Chen, Z.W.; Chang, C.S.; Leil, T.A.; Olcese, R.; Olsen, R.W. GABAA receptor-associated protein regulates GABAA receptor cell-surface number in Xenopus laevis oocytes. Mol. Pharmacol., 2005, 68, 152-159.
40. Kobayashi, T.; Washiyama, K.; Ikeda, K. Pregnenolone sulfate potentiates the inwardly rectifying K channel Kir2.3. PLoS ONE, 2009, 4, e6311.
41. Pau, D.; Belelli, D.; Callachan, H.; Peden, D.R.; Dunlop, J.I.; Peters, J.A.; Guitart, X.; Gutierrez, B.; Lambert, J.J. GABAA receptor modulation by the novel intravenous general anaesthetic E-6375. Neuropharmacology, 2003, 45, 1029-1040.
42. Mascia, M.P.; Asproni, B.; Busonero, F.; Talani, G.; Maciocco, E.; Pau, A.; Cerri, R.; Sanna, E.; Biggio, G. Ethyl 2-(4-bromophenyl)-1-(2,4-dichlorophenyl)-1H-4-imidazolecarboxylate is a novel positive modulator of GABAA receptors. Eur. J. Pharmacol., 2005, 516, 204-211.
43. Granger, R.E.; Campbell, E.L.; Johnston, G.A. (+)-And (-)-borneol: efficacious positive modulators of GABA action at human recombinant alpha1beta2gamma2L GABA(A) receptors. Biochem. Pharmacol., 2005, 69, 1101-1111.
44. Campbell, E.L.; Chebib, M.; Johnston, G.A. The dietary flavonoids apigenin and (-)-epigallocatechin gallate enhance the positive modulation by diazepam of the activation by GABA of recombinant GABA(A) receptors. Biochem. Pharmacol., 2004, 68, 1631-1638.
45. Abdullah J.M. Interesting asian plants: their compounds and effects on electrophysiology and behaviour. Malays. J. Med. Sci., 2011, 18, 1-4.